These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5173322)

  • 1. [Antigenicity of anti-rabies vaccine inactivated by acetyl-ethylen-imine, beta-propiolactone and phenol].
    Cunha RG; Da Silva RA
    Rev Bras Biol; 1971 Dec; 31(4):435-40. PubMed ID: 5173322
    [No Abstract]   [Full Text] [Related]  

  • 2. [Potency studies of sample rabies vaccine, inactivated by beta-propiolactone].
    Akan E
    Turk Hij Tecr Biyol Derg (1961); 1976; 36(2):172-88. PubMed ID: 1023462
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunogenicity of the rabies virus treated with phenol, beta-propiolactone and heat].
    Sazanova EIa; Kuznetsova SV; Kuznetsov PP; Ivanov VS
    Veterinariia; 1980 Mar; (3):32-3. PubMed ID: 7395053
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of beta-propiolactone in duck embryo rabies vaccine.
    Peck FB
    Vox Sang; 1969 Jul; 17(1):62-3. PubMed ID: 5798765
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity of rabies virus inactivated by -propiolactone, acetylethyleneimine, and ionizing irradiation.
    Wiktor TJ; Aaslestad HG; Kaplan MM
    Appl Microbiol; 1972 May; 23(5):914-8. PubMed ID: 5031561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rabies vaccine (Babeş strain of fixed rabies virus) inactivated with betapropiolactone.
    Toacsen E; Serban O; Moraru S
    Arch Roum Pathol Exp Microbiol; 1981; 40(4):333-9. PubMed ID: 7340722
    [No Abstract]   [Full Text] [Related]  

  • 7. Rabies vaccine prepared from the virus grown in Japanese quail embryo cell cultures.
    Bektemirova MS; Pille ER; Matevosyan KS; Nagieva FG
    Acta Virol; 1983 Jan; 27(1):59-64. PubMed ID: 6133431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic prevention of rabies. IV. Experimental evaluation of antigenic efficacy of a vaccine obtained from the brain of suckling rats].
    Mastroeni I; Simonetti AD; D'Arca SU; Tarsitani G; Vescia N
    Nuovi Ann Ig Microbiol; 1975; 26(6):365-78. PubMed ID: 1233459
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inactivated rabies vaccine, produced from a cell culture. Preliminary results].
    Branche R; Lang R; Petermann HG; Soulebot JP
    Prog Immunobiol Stand; 1967; 3():144-50. PubMed ID: 4908593
    [No Abstract]   [Full Text] [Related]  

  • 10. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purified chick embryo cell (PCEC) rabies vaccine for human use. Laboratory data.
    Barth R; Gruschkau H; Jaeger O; Milcke L; Weinmann E
    Behring Inst Mitt; 1984 Nov; (76):142-54. PubMed ID: 6525146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative determination of rabies antigen by ELISA.
    van der Marel P; van Wezel AL
    Dev Biol Stand; 1981; 50():267-75. PubMed ID: 7341294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of rabies vaccine freed of neuroallergenic factor from brain tissue.
    Pille ER; Karakuyumchan MK; Nadaichik LV
    Acta Virol; 1981 Sep; 25(5):304-8. PubMed ID: 6118049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgE and IgG antibodies to beta-propiolactone and human serum albumin associated with urticarial reactions to rabies vaccine.
    Swanson MC; Rosanoff E; Gurwith M; Deitch M; Schnurrenberger P; Reed CE
    J Infect Dis; 1987 May; 155(5):909-13. PubMed ID: 3559291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on beta-propiolactone inactivated suckling mouse brain antirabies vaccine.
    Mathew T; Chowdhuri AN; Bhola SR; Topa PK
    Indian J Med Res; 1978 Aug; 68():197-203. PubMed ID: 721195
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody response to an anti-rabies vaccine in a dog population under field conditions in Bolivia.
    Suzuki K; González ET; Ascarrunz G; Loza A; Pérez M; Ruiz G; Rojas L; Mancilla K; Pereira JA; Guzman JA; Pecoraro MR
    Zoonoses Public Health; 2008 Oct; 55(8-10):414-20. PubMed ID: 18399941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic and immunogenic properties of components contained in rabies virus-infected tissue culture fluids.
    Schlumberger HD; Wiktor TJ; Koprowski H
    J Immunol; 1970 Aug; 105(2):291-8. PubMed ID: 5433693
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement fixing antigen in rabies. V. Effect of bacteriostatic agents on its stability.
    Rai Chowdhuri AN; Bhardwaj M; Sivaraman CA
    J Commun Dis; 1980 Sep; 12(3):144-7. PubMed ID: 7229311
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigenic and molecular characterization of field and vaccine rabies virus strains in the Russian Federation.
    Metlin AE; Rybakov SS; Gruzdev KN; Neuvonen E; Cox J; Huovilainen A
    Dev Biol (Basel); 2006; 125():33-7. PubMed ID: 16878458
    [No Abstract]   [Full Text] [Related]  

  • 20. INFECTION OF THE ONE-DAY OLD FERTILE HEN'S EGG WITH RABIES VIRUS. VIII. BETA-PROPIOLACTONE INACTIVATED VACCINE PRODUCED BY INOCULATION OF ONE-DAY EGGS WITH NISHIGAHARA-O30-M (NOPM) STRAIN.
    YOSHINO K; SAITO K
    Arch Gesamte Virusforsch; 1963 Aug; 13():489-98. PubMed ID: 14078840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.